Share: Facebook Twitter LinkedIn
Activity Provided By:

Integritas Communications

Clinical Profiles of Current and Emerging GLP-1 RAs (Module 1 of 4)

Access Activity

Overview / Abstract:

This CME-accredited CME Snapshotâ„¢ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agonists (GLP-1 RAs). The faculty will also review freely available patient- and caregiver directed educational resources that seek to improve shared decision-making.

Expiration

Aug 08, 2019

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

0.25

Accreditation

ACCME, ANCC, CE

Presenters / Authors / Faculty

John E. Anderson, MD; Jack L. Leahy, MD

Sponsors / Supporters / Grant Providers

This activity has been supported by independent educational grants from Novo Nordisk Inc and jointly provided by the Elsevier Office of Continuing Medical Education, Dannemiller, and Integritas Communications.

Keywords / Search Terms

Integritas Communications Integritas Communications, CME, CE, Free CME, Free CE, Continuing Medical Education, Continuing Education, Video, Webinar, Elsevier, ANCC, American Nurses Credentialing Center, CME Snapshot, Anderson, Leahy, GLP-1 RAs, glucagon-like peptide 1 receptor agonists, T2DM, type 2 diabetes Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map